Learn how other UK businesses have used external finance to reach their ambition
Here’s just some of the tens of thousands of smaller businesses funded through our partners, with the support of British Business Bank’s programmes.
Displaying 1 - 11 of 11 results
Showing 1 - 11 of 11 results
Butternut Box
Originally founded in 2016 by Kevin Glynn and David Nolan, Butternut Box is a London based company that operates across the UK and Europe providing personalised, human quality fresh dog food via a subscription service.
Vyta Secure Ltd
Vyta provides secure IT Asset Disposition (ITAD) services to clients throughout the UK & Ireland. Started in 2001 and originally based in Northern Ireland, it expanded to Dublin in 2008.
Beauty Pie
Beauty Pie is a beauty and wellness brand that gives its members access to owned products sourced from the world’s best labs at up to 70% off traditional retail prices.
Hook & Son
British Business Investments delivery partner FOLK2FOLK specialises in providing finance to underserved smaller businesses within regional areas of the UK.
Gymfinity Kids
Gymfinity Kids, established in 2017, operate a series of activity clubs for children aged 3+ across six sites.
Xampla
Xampla has developed an entirely new generation of materials, made from plants, that replaces plastics.
Ori Biotech
Ori Biotech’s mission is to eliminate barriers to patient access of cell and gene therapies (CGTs) through the use of innovation and by rethinking how those therapies are manufactured.
Quantexa
Quantexa is a data and analytics specialist which has developed a software platform for organisations to help them make meaningful, evidence-based decision using data and machine learning.
Thought Machine
Thought Machine is providing the next generation of core banking platforms using software it has built natively for cloud infrastructure to help banks move away from a reliance on outdated IT infrastructure.
Alchemab Therapeutics
Alchemab Therapeutics is a healthcare company that is harnessing the power of naturally protective antibodies to develop novel products for patients with hard-to-treat diseases.
Elasmogen
Part of a cluster of biotech companies in Aberdeen, Elasmogen uses its bespoke technology platform to isolate innovative drugs for treating cancers and auto-immune diseases.